Outpatient Endometrial Ablation

Barbara Schroeder, MD is proud to offer minimally invasive treatment for heavy and/or painful bleeding in Houston with outpatient endometrial ablation. Dr. Schroeder uses Novasure technology to treat these symptoms simply and effectively allowing patients to return home the same day as their procedure.

This technology has been in use for more than 15 years and shows significant results in reducing menstrual bleeding.

The Novasure Procedure

Novasure endometrial ablation is considered to be a minimally invasive procedure that is safe, quick, and simple. It is recommended for premenopausal women who suffer from abnormal uterine bleeding (AUB). Endometrial ablation is contraindicated for women who plan to get pregnant or those suffering from certain gynecological cancers.

To complete a Novasure endometrial ablation, the patient will receive general anesthesia. During the procedure, Dr. Schroeder will use a speculum to hold the vaginal walls open, giving access to the uterus. There are no incisions necessary to complete the procedure. A thin wand is then inserted into the uterus and extends a triangular mesh device inside the uterus. This device will expand to fit the size and shape of the patient’s uterus.

At this point, precisely measured radiofrequency energy is delivered through the mesh device for approximately 90 seconds, ablating the endometrium. Once complete, the mesh device is retracted back into the wand and removed from the uterus. The entire ablation procedure takes about five to ten minutes to complete. The patient will be monitored for a short period immediately after the procedure before being discharged to go home.

Recovery from Novasure

Recovery from Novasure endometrial ablation is relatively simple and brief. The patient may experience minor cramps, and vaginal discharge in the days after the procedure. There may be mild vaginal bleeding, so the patient can wear a pad during this time. After recovery, the severe menstrual bleeding should be significantly reduced if not stopped altogether. Studies have shown that 77.7% of women who receive Novasure treatment see a major reduction in their menstrual bleeding within one year.